Summary
Gilead Sciences, Inc. (GILD) filed an 8-K report on February 4, 2020, to announce its financial results for the fourth quarter and full year ended December 31, 2019. The report primarily directs investors to the press release filed as Exhibit 99.1, which contains detailed financial information, including both GAAP and non-GAAP measures. Management utilizes non-GAAP financial information for internal operational, budgeting, and planning purposes, believing it offers a useful supplemental view for investors alongside GAAP financial statements. Investors are encouraged to review the reconciliation tables provided in the press release to understand the differences between GAAP and non-GAAP figures. The filing also notes that this information is not considered "filed" for purposes of Section 18 of the Securities Exchange Act, nor is it incorporated by reference into other filings.
Key Highlights
- 1Gilead Sciences announced its Q4 and full-year 2019 financial results on February 4, 2020.
- 2The 8-K filing includes a press release (Exhibit 99.1) containing the detailed financial results.
- 3Both GAAP and non-GAAP financial information are presented in the press release.
- 4Management uses non-GAAP measures internally for operational and planning purposes.
- 5Investors are advised to use non-GAAP information as a supplement to GAAP results.
- 6A reconciliation between GAAP and non-GAAP financial measures is available in the press release.
- 7The information provided in the 8-K and exhibit is not deemed 'filed' under Section 18 of the Exchange Act.